Bacterial Pneumonia — Patent Landscape
4
Approved drugs
30
Active US patents
57/100
Avg vulnerability
—
Annual revenue covered
Originators in Bacterial Pneumonia
Cliff calendar — next 15 years
2
26
4
27
5
29
6
30
1
31
6
34
5
37
Approved drugs ranked by patent estate
| Drug | Originator | Active patents | Avg vuln | Revenue | First cliff |
|---|---|---|---|---|---|
|
Amoxil
amoxicillin
|
Generic (originally Beecham/GSK) | 14 | 58 | — | 2026-12-08 |
|
Nuzyra
OMADACYCLINE TOSYLATE
|
Paratek Pharms | 13 | 61 | — | 2029-03-05 |
|
Vibativ
TELAVANCIN HYDROCHLORIDE
|
Cumberland | 2 | 27 | — | 2027-01-01 |
|
Vibramycin
doxycycline
|
Generic (originally Pfizer) | 1 | 80 | — | 2027-12-19 |
Most attackable patents
| Patent | Drug | Type | Vuln | Expiry |
|---|---|---|---|---|
| 8299052 | Amoxil | method of use | 85 | 2027-05-07 |
| 8778924 | Amoxil | method of use | 80 | 2026-12-08 |
| 7749532 | Vibramycin | method of use | 80 | 2027-12-19 |
| 9724358 | Nuzyra | method of use | 75 | 2029-03-05 |
| 10124014 | Nuzyra | method of use | 75 | 2029-03-05 |
| 10124014 | Nuzyra | method of use | 75 | 2029-03-05 |
| 9724358 | Nuzyra | method of use | 75 | 2029-03-05 |
| 11931463 | Amoxil | method of use | 75 | 2034-02-12 |
| 11878011 | Amoxil | method of use | 75 | 2042-05-27 |
| 9265740 | Nuzyra | method of use | 68 | 2030-10-24 |
Strongest defences
| Patent | Drug | Type | Vuln | Expiry |
|---|---|---|---|---|
| 8383610 | Nuzyra | composition of matter | 10 | 2030-09-23 |
| 7977488 | Amoxil | composition of matter | 18 | 2030-04-10 |
| 7977488 | Amoxil | composition of matter | 18 | 2030-04-10 |
| 7531623 | Vibativ | composition of matter | 27 | 2027-01-01 |
| 7531623 | Vibativ | composition of matter | 27 | 2027-01-01 |
| 10238606 | Amoxil | formulation | 42 | 2034-02-12 |
| 9314475 | Nuzyra | formulation | 48 | 2031-03-18 |
| 9265740 | Nuzyra | formulation | 55 | 2029-03-05 |
| 9186411 | Amoxil | formulation | 56 | 2030-08-11 |
| 9186411 | Amoxil | formulation | 56 | 2030-08-11 |
Related
- Bacterial Pneumonia — full disease profile
- AI Patent Landscape Report — type "bacterial pneumonia" for an AI exec memo
- Company Patent Rankings
- Biosimilar Opportunity Scanner